Does CyberKnife improve dose distribution versus IMRT and VMAT on a linear accelerator in low-risk prostate cancer? CyberKnife, IMRT and VMAT in low risk prostate cancer. Radiol Oncol. 2022;56(2):259-266. Accessed September 22, 2026. https://www.radioloncol.com/index.php/ro/article/view/3786